Filing Details
- Accession Number:
- 0001415889-25-006307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 20:22:34
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 20:22:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1836958 | James Michel Voigt | 1600 West Merit Parkway South Jordan UT 84095 | Chief Human Resources Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2025-02-27 | 11,533 | $0.00 | 21,441 | No | 4 | A | Direct | |
Common Stock, No Par Value | Disposition | 2025-02-27 | 4,530 | $98.50 | 16,911 | No | 4 | F | Direct | |
Common Stock, No Par Value | Acquisiton | 2025-02-28 | 5,488 | $0.00 | 22,399 | No | 4 | A | Direct | |
Common Stock, No Par Value | Acquisiton | 2025-02-28 | 7,261 | $56.25 | 29,660 | No | 4 | M | Direct | |
Common Stock, No Par Value | Acquisiton | 2025-02-28 | 4,048 | $65.03 | 33,708 | No | 4 | M | Direct | |
Common Stock, No Par Value | Acquisiton | 2025-02-28 | 2,500 | $70.58 | 36,208 | No | 4 | M | Direct | |
Common Stock, No Par Value | Disposition | 2025-02-28 | 13,809 | $99.68 | 22,399 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2025-02-28 | 7,261 | $0.00 | 9,681 | $56.25 |
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2025-02-28 | 4,048 | $0.00 | 8,094 | $65.03 |
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2025-02-28 | 2,500 | $0.00 | 13,576 | $70.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,420 | 2022-03-19 | 2028-03-19 | No | 4 | M | Direct |
4,046 | 2023-02-28 | 2029-02-28 | No | 4 | M | Direct |
11,076 | 2024-02-28 | 2030-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, No Par Value | 15 | Indirect | By 401(k) Plan |
Footnotes
- Represents plan holdings as of 02/28/2025.
- These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022.
- The Reporting Person surrendered 4,530 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
- Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.425 to $100.485, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
- Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- Become exercisable in equal annual installments of 25% commencing on 02/28/2024.